Oliver O’Connor
Oliver O’Connor is the Chief Executive of the Irish Pharmaceutical Healthcare Association (Ipha), a leading organization representing the interests of the pharmaceutical industry in Ireland. He has been vocal about the need for reform in the healthcare system to ensure faster and fairer access to new medicines for patients. O'Connor emphasizes the importance of collaboration between the government and the pharmaceutical industry to improve the approval process for drugs and reduce waiting times for patients. His recent comments highlight the significant delays faced by Irish patients in accessing new therapies, which can take nearly three times longer than the intended timeframe.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Ireland | 1 | 6.00 | 0.04% | +10% | 5,030,000 | 2,314 | $5,100 | 2$ |
| Totals | 1 | 5,030,000 | 2,314 | $5,100 | 2$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Ireland:
IPHA chief executive Oliver O’Connor said the industry 'has a significant footprint in Ireland, employing 50,000 highly skilled people'.
6
Ireland:
Oliver O’Connor, head of the Irish pharmaceutical lobby group, warned against cutting regulatory protection.
5
Ireland:
Ipha chief executive Oliver O’Connor said the State now has an opportunity to effectively reform the system and meet the goal of faster and fairer access to new medicines for patients in Ireland.
8